Jupiter Life Line Hospitals (JLHL) Q4 22/23 earnings summary

Executive summary

• Healthcare operations comprised 366 operational beds in Thane, 353 in Pune and a 231-bed hospital in Indore through a subsidiary.

• Standalone profit after tax rose to Rs. 1,072.14 million from Rs. 846.71 million in FY2022; consolidated revenue also increased year over year.

Financial highlights

• Consolidated revenue from operations was Rs. 8,925.43 million vs Rs. 7,331.23 million; total revenue was Rs. 9,029.63 million vs Rs. 7,371.44 million in FY2022.

• Consolidated PBDT was Rs. 1,694.67 million vs Rs. 1,134.74 million; reported profit before tax was Rs. 1,287.08 million vs Rs. 771.18 million.

• Standalone revenue from operations was Rs. 7,873.22 million vs Rs. 6,572.79 million; total income was Rs. 8,006.17 million vs Rs. 6,610.33 million.

• Standalone profit after tax was Rs. 1,072.14 million vs Rs. 846.71 million; basic EPS was Rs. 20.58 vs Rs. 16.65, and diluted EPS was Rs. 19.11 vs Rs. 16.65.

Outlook and guidance

• Plans to pursue listings on NSE and BSE in FY2023-24; Draft Red Herring Prospectus filed with SEBI on 11 May 2023.